#TBT last year’s Massachusetts Conference for Women! Our team had a great time connecting with #womenleaders and hearing from? #TeamLantheus leader Dottie Barr as she participated in a panel discussion.? ? This year, we’re excited that our Chief Commercial Officer, Amanda Morgan, will be participating in a panel about new work environments.?? ? We hope to see you there!??
关于我们
About us With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in Canada and Sweden.
- 网站
-
https://www.lantheus.com/
Lantheus的外部链接
- 所属行业
- 制药业
- 规模
- 501-1,000 人
- 总部
- Bedford，Massachusetts
- 类型
- 上市公司
- 创立
- 1956
- 领域
- Precision diagnostics、Targeted therapeutics、Radiopharmaceutical oncology、Artificial intelligence solutions、Strategic partnerships和Just-in-time manufacturing
地点
Lantheus员工
动态
-
We’re excited to welcome Leo Weihe, our Ethics and Compliance Co-op, to our #CoOpCorner! A third-year Business and Economics major at Northeastern University, Leo has made great strides in enhancing his organizational, analytical, and communication skills during his time at #Lantheus. Currently, he’s focused on organizing and automating service systems across various teams—an impactful project that showcases his dedication and talent. Originally from Austin, Texas, Leo enjoys hiking, playing poker, and cheering for the New Orleans Saints. We’re thrilled to have you on board with us, Leo!?
-
#NEWS: #Lantheus today announced that the Company’s board of directors has authorized a program to repurchase up to $250 million of its common stock over the next twelve months.?? ? Read the full release here: https://bit.ly/3CDSZRC?? ? #LNTH #LeadingRadiopharma?#FindFightFollow?
-
-
#ICYMI, the Centers for Medicare & Medicaid Services issued their final ruling for CY25 earlier this month – a decision that will ensure broader patient access to critically needed radiodiagnostics. Check out the highlights in the #SNMMI reimbursement update below. ???
A big victory for patients and the nuclear medicine field! After 16?years of advocacy and collaboration, the Centers for Medicare and Medicaid Services has announced the unbundling of diagnostic radiopharmaceuticals at the $630 level. This will open up access to nuclear medicine scans, altering the course of treatment for patients who need it the most, as well as spur innovation and production in the pharmaceutical industry. SNMMI applauds CMS for this significant improvement in access to nuclear medicine. This is a community victory that came from a community effort — your voices in support of this important cause had a great impact. SNMMI will continue to work with CMS to ensure equitable access to diagnostic care for all. Read more here: https://lnkd.in/eKEctfT4
-
At #TeamLantheus, embracing our Value to Own The Solution and Make It Happen is not just a principle; it's a commitment that propels us to relentless action. We tirelessly champion #cancerresearch and causes close to our hearts, while also dedicating ourselves to delivering innovative radiodiagnostics and radiotherapeutics. Join us in our Purpose to #FindFightFollow disease to deliver better patient outcomes.? ? https://bit.ly/LNTHLife? #OwnTheSolution?#MakeItHappen?#LantheusValues?
-
This #NationalFamilyCaregiversMonth, we’re continuing to raise awareness of the important role caregivers play in the lives of patients.?? ? We recently spoke with Khadijah, a daughter who reflects on her father’s turbulent health journey. In spite of the obstacles, she and her father remain resilient in the face of #prostatecancer and are inspiring others to know the facts about this disease.? ? The strength and commitment to advocacy demonstrated by caregivers is just one of the many reasons we’re honoring #NFCM!??
-
This past fall, #TeamLantheus traveled across the country to hear about advances in urological care! We were pleased to network with and learn from industry peers at regional meetings held by the American Urological Association as part of our Purpose to #FindFightFollow #prostatecancer.?? ?? #AUA??
-
Last month, our team stepped up to build a brighter future for patients by participating in both the #BostonHeartWalk and the #Walk2EndAlz. #Lantheus is proud to take a stand for those living with #heartdisease and #AlzheimersDisease through these events. It helps inspire and validates our Purpose to #FindFightFollow disease to deliver better patient outcomes. Check out some highlights from the walks below!? ? #FindFightFollow?
-
Join us tomorrow at the LUGPA 2024 Annual Meeting from 12:00 – 1:00 pm CT for our lunch symposium!?? ? Dr. Steven Finkelstein MD FACRO and Dr. David Albala will be presenting on “The Power of PSMA PET Imaging in the Management of Prostate Cancer.” We hope to see you there!?
-
-
In celebration of #WorldQualityWeek, we recognize our Quality team and the instrumental work they do to ensure excellence and positively impact the lives of as many patients as possible through our innovative radiodiagnostics and therapeutics. To commemorate this observance, our Quality team gathered and shared insights on streamlining processes and revolutionizing quality.? ? For more about WQW, check out these resources from CQI | The Chartered Quality Institute and IRCA | International Register of Certificated Auditors: https://bit.ly/4eLRLC2?? ? #GoFurther?